A. Pasternak and M. Nazzal, “Pharmacogenetic Considerations for Irinotecan Therapy”, SMART-MD J. Precision Med., vol. 1, no. 3, pp. e49-e54, Dec. 2024, doi: 10.69734/1syww840.